Skip to main navigation Skip to search Skip to main content

Erratum: Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome (American Journal of Physiology - Renal Physiology (2018) 314 (F602-F613) DOI: 10.1152/ajprenal.00207.2017)

  • X. Nie
  • , M. A. Chanley
  • , R. Pengal
  • , D. B. Thomas
  • , S. Agrawal
  • , W. E. Smoyer

Research output: Contribution to journalComment/debate

Abstract

In the original article, there was an error in Fig. 6, I and K, as published. The authors accidentally used the same images inFig. 6, C and I, alongwithFig. 6, E and K. The authors have added the correct images for the ADR-treated MK3/ group in Fig. 6I and for the ADR-treated MK2/MK3/ group in Fig. 6K. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The corrected Fig. 6 with legend appears below.

Original languageEnglish
Pages (from-to)F573-F574
JournalAmerican Journal of Physiology - Renal Physiology
Volume322
Issue number5
DOIs
StatePublished - May 2022

Fingerprint

Dive into the research topics of 'Erratum: Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome (American Journal of Physiology - Renal Physiology (2018) 314 (F602-F613) DOI: 10.1152/ajprenal.00207.2017)'. Together they form a unique fingerprint.

Cite this